Simple hygiene advice may protect unborn babies from common virus
NCT ID NCT03443791
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether teaching pregnant women about hygiene habits can reduce their risk of catching cytomegalovirus (CMV) and passing it to their baby. Researchers will enroll 200 pregnant women in Brazil and provide counseling on behaviors like handwashing. The goal is to cut congenital CMV infections by half.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- behavioral intervention (hygiene counseling)
- What this could lead to
- If successful, this simple counseling approach could reduce the number of babies born with congenital CMV infection.
- What could go wrong
- This is an observational study without a control group, so results may not prove cause and effect. The counseling may not change behavior enough to lower infection rates.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
200 people
The number who actually took part.
- Started
-
Sep 2022
- Finished
-
Dec 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
1 hour to 35 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion: * Women in Ribeirao Preto who receive maternity care through the Hospital Das Clinicas, University of São Paulo and the Mater Hospital * enrollment in prenatal care before 23 weeks gestation Exclusion: * late enrollment in prenatal care, after 23 weeks gestation * known major fetal anomalies or demise * planned termination of pregnancy * intention of the patient to deliver at a non-study hospital * referral for high risk prenatal care
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CMV congenital are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Sao Paulo
São Paulo, Brazil
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an antiviral drug protect hearing in infants with congenital CMV?
- New drug may offer safer CMV prevention for kidney transplant patients
- Could a common virus help brain tumors grow? new trial tests Anti-Viral drug in breast cancer patients
- Heart transplant patients may get safer virus protection